RA Capital Management, L.P. 13D and 13G filings for SAB Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-23 4:25 pm Purchase | 2026-03-19 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | RA Capital Management, L.P. | 7,311,225 9.900% | 2,144,801 (+41.51%) | Filing |
| 2026-03-11 4:43 pm Purchase | 2026-03-09 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | RA Capital Management, L.P. | 5,166,424 9.900% | 764,924 (+17.38%) | Filing |
| 2025-10-03 4:26 pm Purchase | 2025-09-26 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | RA Capital Management, L.P. | 4,401,500 9.900% | 4,401,500 (New Position) | Filing |